Related Experiment Video
Updated: Nov 9, 2025

Isolation and Functional Analysis of Mitochondria from Cultured Cells and Mouse Tissue
Published on: March 23, 2015
Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis
Hudie Wei1, Lingzhi Qu1, Shuyan Dai1
1Department of Oncology, NHC Key Laboratory of Cancer Proteomics, Laboratory of Structural Biology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
The tumor suppressor p53 is mutated in approximately half of all human cancers. p53 can induce apoptosis through mitochondrial membrane permeabilization by interacting with and antagonizing the anti-apoptotic proteins BCL-xL and BCL-2. However, the mechanisms by which p53 induces mitochondrial apoptosis remain elusive. Here, we report a 2.5 Å crystal structure of human p53/BCL-xL complex. In this structure, two p53 molecules interact as a homodimer, and bind one BCL-xL molecule to form a ternary complex with a 2:1 stoichiometry. Mutations at the p53 dimer interface or p53/BCL-xL interface disrupt p53/BCL-xL interaction and p53-mediated apoptosis. Overall, our current findings of the bona fide structure of p53/BCL-xL complex reveal the molecular basis of the interaction between p53 and BCL-xL, and provide insight into p53-mediated mitochondrial apoptosis.
Insights
The tumor suppressor protein p53, mutated in many cancers, induces apoptosis by binding BCL-xL. This study reveals the p53/BCL-xL complex structure, clarifying how p53 triggers cell death.
Area of Science:
- Molecular Biology
- Structural Biology
- Cancer Research
Background:
- The tumor suppressor p53 is frequently mutated in human cancers.
- p53 induces apoptosis via mitochondrial membrane permeabilization.
- p53 antagonizes anti-apoptotic proteins BCL-xL and BCL-2, but the mechanism is unclear.
Purpose of the Study:
- To elucidate the molecular mechanism of p53-mediated mitochondrial apoptosis.
- To determine the structural basis of the interaction between p53 and BCL-xL.
Main Methods:
- X-ray crystallography of the human p53/BCL-xL complex.
- Analysis of mutations at p53 and p53/BCL-xL interfaces.
Main Results:
- A 2.5 Å crystal structure of the human p53/BCL-xL complex was determined.
- The structure reveals a ternary complex with 2:1 stoichiometry (p53:BCL-xL).
- Mutations disrupting p53 dimerization or the p53/BCL-xL interface abolish apoptosis.
Conclusions:
- The study provides the bona fide structure of the p53/BCL-xL complex.
- This structure reveals the molecular basis for p53's interaction with BCL-xL.
- The findings offer insights into p53-mediated mitochondrial apoptosis and its role in cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Abnormal Proliferation
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
The Extrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle

